EP Patent

EP1214062B1 — Use of nicotinic acetylcholine receptor agonists for the preparation of a medicament for the treatment of dry eye disease

Assigned to Inspire Pharmaceuticals Inc · Expires 2003-11-12 · 23y expired

What this patent protects

Patent listed against varenicline-tartrate.

Drugs covered by this patent

varenicline-tartrate (VARENICLINE TARTRATE)

Patent Metadata

Patent number: EP1214062B1
Jurisdiction: EP
Classification: —
Expires: 2003-11-12
Drug substance claim: No
Drug product claim: No
Assignee: Inspire Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.